Two AI Penny Stocks to Buy in 2026

After rocking the stock market last year and taking it to record highs, AI stocks are keeping up with the momentum this year. The demand for AI stocks is at an all-time high, and no one can deny their disruptive quality and long-term potential. With so many lucrative AI stocks to choose from, investors are spoiled for choice going into the second half of the year.

• AI stocks are in high demand, and there are loads of options to choose from, including super cheap and undervalued.
• Guardforce AI is an emerging player in the AI robotics & security space, performing impressively in the stock market recently, with some recent acquisitions that have caught the attention of high-profile investors.
• Predictive Oncology is another impressive company carving a path in the AI and pharmaceutical space.

With the current demand and attention on AI stocks, it would be incredibly short-sighted not to own one. Joel Lim, financial analyst at Trading.biz, has identified two AI penny stocks that every investor should buy.

Guardforce AI

Guardforce AI is an interesting company that delivers robotics-based security solutions through AI services. Their use case is one of the more unique ones in the AI space, making them not only a different investment profile but also a company with massive potential. In the AI x Robotics security space, they are a frontrunner light years ahead of the competition.

They’ve also produced impressive numbers in the last year. Their recent quarterly revenue reports beat analyst estimates, and their free cash flow balance stands at an impressive $11 million. They’ve also made some impressive acquisitions and collaborations that should interest investors.

In the last year, they’ve bought assets from Shenzhen Kewei Robot Technology, a robot-related business, and collaborated with Concorde Security, another major player in the security space.

Joel Lim notes, “Regarding AI penny stocks, Guardforce AI is one of the more attractive options thanks to its first-mover advantage and massive growth potential.”

Predictive Oncology

Predictive Oncology is an impressive AI company that leverages AI technology to improve the drug discovery process and develop effective medical treatments. Its growth and contribution to the AI-led discovery market make it an absolute must-have AI stock. According to recent reports, the AI-led discovery market is estimated to grow to around $4.9 billion by 2028.

With the emerging trend of AI use in pharmaceutical research and development, it’s only a matter of time before stocks like Predictive Oncology explode in the market. Investing in it now that the stock is under $10 could be a smart decision in the long run.

Joel Lim notes, “Predictive Oncology presents a great opportunity for low-cap investors looking to participate to invest in a low-priced AI stock. Its potential for massive long-term gains is evident to see.”